Oxidative stress hypothesis in Alzheimer's disease: a reappraisal.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  TIPS - Trends in Pharmacological Sciences

• Publication date

  2008-12-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1016/j.tips.2008.09.001PMID 18838179
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model.

  2009cited by this paper
• Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease.

  2008cited by this paper
• Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI.

  2008cited by this paper
• Antioxidant Vitamin Supplement Use and Risk of Dementia or Alzheimer's Disease in Older Adults

  2008cited by this paper
• Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease.

  2008cited by this paper
• Thromboxane Receptor Activation Mediates Isoprostane-Induced Increases in Amyloid Pathology in Tg2576 Mice

  2008cited by this paper
• Developing preventive therapies for chronic diseases: lessons learned from Alzheimer's disease.

  2007cited by this paper
• Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.

  2007cited by this paper
• Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study

  2007cited by this paper
• Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease.

  2006cited by this paper
• P3–370: APOE genotype has no influence in platelet and erythrocyte oxidative state

  2006cited by this paper
• β-Amyloid Mediated Nitration of Manganese Superoxide Dismutase: Implication for Oxidative Stress in a APPNLh/NLh X PS-1P264L/P264L Double Knock-In Mouse Model of Alzheimer's Disease

  2006cited by this paper
• Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease.

  2006cited by this paper
• Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease.

  2006cited by this paper
• A randomized trial of vitamin E supplementation and cognitive function in women.

  2006cited by this paper
• Mutations in amyloid precursor protein and presenilin‐1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid β‐peptide (1–42), H2O2 and kainic acid: implications for Alzheimer's disease

  2006cited by this paper
• Deletion of vitamin E enhances phenotype of Alzheimer disease model mouse.

  2006cited by this paper
• Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment

  2006cited by this paper
• Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice.

  2005cited by this paper
• Evidence of increased oxidative damage in subjects with mild cognitive impairment

  2005cited by this paper
• Dementia and Alzheimer's Disease in Community-Dwelling Elders Taking Vitamin C and/or Vitamin E

  2005cited by this paper
• Deletion of the Prostaglandin E2 EP2 Receptor Reduces Oxidative Damage and Amyloid Burden in a Model of Alzheimer's Disease

  2005cited by this paper
• Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment

  2005cited by this paper
• Vitamin E and donepezil for the treatment of mild cognitive impairment.

  2005cited by this paper
• Supplemental Use of Antioxidant Vitamins and Subsequent Risk of Cognitive Decline and Dementia

  2005cited by this paper
• Ribosome Dysfunction Is an Early Event in Alzheimer's Disease

  2005cited by this paper
• Aging‐related increase in oxidative stress correlates with developmental pattern of beta‐secretase activity and beta‐amyloid plaque formation in transgenic Tg2576 mice with Alzheimer‐like pathology

  2004cited by this paper
• Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study.

  2004cited by this paper
• Vitamin E reduces amyloidosis and improves cognitive function in Tg2576 mice following repetitive concussive brain injury

  2004cited by this paper
• Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study.

  2004cited by this paper
• Early Vitamin E supplementation in young but not aged mice reduces Aβ levels and amyloid deposition in a transgenic model of Alzheimer's disease

  2004cited by this paper
• Lipid Peroxidation and Oxidative imbalance: Early functional events in Alzheimer's disease

  2004cited by this paper
• Impact of antioxidants, zinc, and copper on cognition in the elderly

  2004cited by this paper
• Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice

  2004cited by this paper
• Antioxidant vitamin intake and risk of Alzheimer disease.

  2003cited by this paper
• High-dose antioxidant supplements and cognitive function in community-dwelling elderly women.

  2003cited by this paper
• Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease

  2003cited by this paper
• Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Aβ production in APP23 transgenic mice

  2003cited by this paper
• Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease.

  2002cited by this paper
• Vitamin E and cognitive decline in older persons.

  2002cited by this paper
• Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice

  2002cited by this paper
• Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study.

  2002cited by this paper
• Dietary intake of antioxidants and risk of Alzheimer disease.

  2002cited by this paper
• Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis

  2001cited by this paper
• Oxidative Damage Is the Earliest Event in Alzheimer Disease

  2001cited by this paper
• The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse

  2001cited by this paper
• The glial glutamate transporter, GLT‐1, is oxidatively modified by 4‐hydroxy‐2‐nonenal in the Alzheimer's disease brain: the role of Aβ1–42

  2001cited by this paper
• Fibrillar beta-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease.

  2001cited by this paper
• Fibrillar β-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer’s disease

  2001cited by this paper
• Association of vitamin E and C supplement use with cognitive function and dementia in elderly men

  2000cited by this paper
• Fear recognition deficits after focal brain damage

  2000cited by this paper
• Oxidative stress in Alzheimer's disease.

  2000cited by this paper
• Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey.

  1999cited by this paper
• Oxidative Alterations in Alzheimer's Disease

  1999cited by this paper
• Cerebrospinal fluid F2‐isoprostane levels are increased in Alzheimer's disease

  1998cited by this paper
• Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

  1998cited by this paper
• Increased F2‐isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo

  1998cited by this paper
• Use of antioxidant supplements and its association with cognitive function in a rural elderly cohort: the MoVIES Project. Monongahela Valley Independent Elders Survey.

  1998cited by this paper
• Oxidative stress hypothesis in Alzheimer's disease.

  1997cited by this paper
• Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.

  1997cited by this paper
• beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease.

  1997cited by this paper
• A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

  1997cited by this paper
• Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease

  1995cited by this paper
• Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation

  1995cited by this paper
• Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

  1994cited by this paper
• Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.

  1991cited by this paper
• Autopsy Samples of Alzheimer's Cortex Show Increased Peroxidation In Vitro

  1990cited by this paper

• Design, synthesis and pharmacological evaluation of coumarin tethered 1,3,4-oxadiazole conjugates as dual binding site acetylcholinesterase ligands targeting Alzheimer's disease.

  2026cites this paper
• Roles of Reactive Oxygen Species in Relationships Between Viral Infections and Alzheimer’s Disease and Related Dementia

  2026cites this paper
• Synthesis of cinnamic esters and acids via palladium-catalyzed reactions of aryl diazonium salts and their biological evaluation.

  2026cites this paper
• Discovery of 3-benzyloxy-6-arylpyridazine derivatives as novel multi-target agents toward Parkinson's disease therapy.

  2026cites this paper
• Amyloid-β and Tau in Alzheimer’s disease: pathogenesis, mechanisms, and interplay

  2026cites this paper
• Tailored brain metastatic tumor cells-derived apoptotic bodies ameliorate Alzheimer’s disease by promoting microglia efferocytosis and neuroinflammation mitigation

  2025cites this paper
• Stress, Stress Management, and Dementia: A Narrative Review

  2025cites this paper
• Idebenone improves mitochondrial respiratory activity and attenuates oxidative damage via the SIRT3-SOD2 pathway in a prion disease cell model.

  2025cites this paper
• Small-molecule fluorescent probes for imaging intracellular amyloid toxicity induces ferroptosis via HClO fluctuation in Alzheimer's disease.

  2025cites this paper
• Identification of critical genes and drug repurposing targets in entorhinal cortex of Alzheimer’s disease

  2025cites this paper
• NADPH Oxidase Inhibition Promotes Brain Resilience by Attenuating Tauopathy and Neuroinflammation in Alzheimer's Disease

  2025cites this paper
• Promotion of cellular differentiation and DNA repair potential in brain cancer cells by Shankhpushpi, (Clitoria ternatea L.) with rasayana properties in vitro

  2025cites this paper
• Advancing Nanomaterial-Based Strategies for Alzheimer’s Disease: A Perspective

  2025cites this paper
• Exploring the Link Between Periodontitis and Alzheimer’s Disease—Could a Nanoparticulate Vaccine Break It?

  2025cites this paper
• Bushen Yinao pill improves cognitive function in Alzheimer's disease rats by regulating PI3K/Akt pathway and intestinal microbiota.

  2025cites this paper
• Pharmacological action, mechanism and structure-activity relationship of traditional Chinese medicine polysaccharide in the treatment of Alzheimer's disease: A review.

  2025cites this paper
• Dual role of microglia in neuroinflammation and neurodegenerative diseases.

  2025cites this paper
• Potential role of dietary whole grains in Alzheimer's Disease: bioactive components, mechanistic insights, and epidemiological evidence

  2025cites this paper
• Glucose Metabolic Reprogramming in Microglia: Implications for Neurodegenerative Diseases and Targeted Therapy

  2025cites this paper
• Investigating the therapeutic potential of 1,2,3,4,6 penta-O-galloyl-β-D-glucose in Alzheimer's disease: a scoping review.

  2025cites this paper
• Innovations in Alzheimer’s disease diagnostic technologies: clinical prospects of novel biomarkers, multimodal integration, and non-invasive detection

  2025cites this paper
• Chemical composition, antioxidant activities, and enzyme inhibitory effects of Lespedeza bicolour Turcz. essential oil

  2025cites this paper
• Quinic acid and its derivatives protect against phytohaemagglutinin-induced Alzheimer's-like neurotoxicity in SH-SY5Y cells by down-regulating p38 MAPK signaling pathway.

  2025cites this paper
• Decoding the Role of Neurotrophins in Glycogen Synthase Kinase 3-Beta Regulation in Alzheimer’s Disease

  2025cites this paper
• Frailty and social contact with dementia risk: A prospective cohort study.

  2025cites this paper
• Photodynamic and Photothermal Therapies using Nanotechnology Approach in Alzheimer's Disease

  2025cites this paper
• Analysis of Intact In Vivo Peroxidized Phospholipids from Bovine Retina via LC-MS/MS and GC-MS/MS Using Autoxidized Retina Reference Standards.

  2024cites this paper
• Advances of curcumin in nervous system diseases: the effect of regulating oxidative stress and clinical studies

  2024cites this paper
• Impact of Peptide Transport and Memory Function in the Brain

  2024cites this paper
• The Influence of Cichorium Endivia and Urtica Dioica Extracts Against H2O2-Induced Stress in SH-SY5Y Cells

  2024cites this paper
• Advances in design strategies and imaging applications of specific butyrylcholinesterase probes

  2024cites this paper
• The role of Sod-2 in different types of neuronal damage and behavioral changes induced by polystyrene nanoplastics in Caenorhabditis elegans.

  2024cites this paper
• Evolving Significance of Kinase Inhibitors in the Management of Alzheimer's Disease.

  2024cites this paper
• Association of oxidative stress and inflammatory metabolites with Alzheimer’s disease cerebrospinal fluid biomarkers in mild cognitive impairment

  2024cites this paper
• Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies

  2024cites this paper
• Exploring the anti-Alzheimer potential: Design, synthesis, biological activity, and molecular docking study of benzothiazol-1,3,4-oxadiazole-acetamide compounds

  2024cites this paper
• Co-administration of coenzyme Q10 and curcumin mitigates cognitive deficits and exerts neuroprotective effects in aluminum chloride-induced Alzheimer's disease in aged mice.

  2024cites this paper
• Biomarker evidence of early vision and rod energy-linked pathophysiology benefits from very low dose DMSO in 5xFAD mice

  2024cites this paper
• Novel Gene Therapy Approaches for Targeting Neurodegenerative Disorders: Focusing on Delivering Neurotrophic Genes

  2024cites this paper
• Synthesis and bio-activities of bifunctional tetrahydrosalen Cu (II) chelators with potential efficacy in Alzheimer's disease therapy.

  2024cites this paper
• In Vitro Evaluation of the Antioxidant Capacity of 3,3-Disubstituted-3H-benzofuran-2-one Derivatives in a Cellular Model of Neurodegeneration

  2024cites this paper
• Effect and Mechanism of Rapamycin on Cognitive Deficits in Animal Models of Alzheimer’s Disease: A Systematic Review and Meta-analysis of Preclinical Studies

  2024cites this paper
• Reactive oxygen species-scavenging nanomaterials for the prevention and treatment of age-related diseases

  2024cites this paper
• Fasting, a Potential Intervention in Alzheimer's Disease.

  2024cites this paper
• Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History

  2024cites this paper
• Luteoloside inhibits Aβ1-42 fibrillogenesis, disintegrates preformed fibrils, and alleviates amyloid-induced cytotoxicity.

  2024cites this paper
• Potential Role of Oxidative Stress in the Pathophysiology of Neurodegenerative Disorders.

  2024cites this paper
• Understanding the mechanisms of disease modifying effects of aerobic exercise in people with Alzheimer's disease.

  2024cites this paper
• Plant-derived extracellular vesicles as potential smart nano drug delivery systems for antioxidant vitamins C and E in Alzheimer's disease

  2024cites this paper
• Hydroxyl chalcone derivative DK02 as a multi‐target‐directed ligand for Alzheimer's disease: A preclinical study in zebrafish

  2024cites this paper
• Indole-3-Carbinol and Its Derivatives as Neuroprotective Modulators

  2024cites this paper
• Mitochondria-targeting near-infrared fluorescence/afterglow sensing assay for the rapid detection of HClO and its application in the early detection of Alzheime's disease

  2024cites this paper
• Experimental verification about treatment of Bu-Shen-Yi-Jing-Fang in Alzheimer’s disease by the analysis of the feasible signaling pathway of network pharmacology

  2024cites this paper
• Effectiveness and mechanisms of combined use of antioxidant nutrients in protecting against oxidative stress‐induced neuronal loss and related neurological deficits

  2024cites this paper
• Multi-target potential of newly designed tacrine-derived cholinesterase inhibitors: Synthesis, computational and pharmacological study.

  2024cites this paper
• Review on anti-alzheimer drug development: approaches, challenges and perspectives

  2024cites this paper
• Glucan Coated Iron Oxide Nanoparticles for Regulating Survival, Inflammation and Oxidative Stress in Parkinsons Disease

  2023cites this paper
• Exploring the therapeutic potential of natural compounds for Alzheimer's disease: Mechanisms of action and pharmacological properties.

  2023cites this paper
• Discovery of novel benzofuran-based derivatives as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease: Design, synthesis, biological evaluation, molecular docking and 3D-QSAR investigation.

  2023cites this paper
• Multifunctional Gomisin B enhances cognitive function in APP/PS1 transgenic mice by regulating Aβ clearance and neuronal apoptosis.

  2023cites this paper
• Impact of common ALDH2 inactivating mutation and alcohol consumption on Alzheimer’s disease

  2023cites this paper
• Mitochondrial vulnerability to oxidation in human brain organoids modelling Alzheimer's disease.

  2023cites this paper
• Endoplasmic reticulum stress in Alzheimer's disease: Molecular mechanisms and therapeutic prospects.

  2023cites this paper
• The Neurobiology and Therapeutic Potential of Multi-Targeting β-secretase, Glycogen Synthase Kinase 3β and Acetylcholinesterase in Alzheimer's Disease.

  2023cites this paper
• Alzheimer’s Disease and Green Tea: Epigallocatechin-3-Gallate as a Modulator of Inflammation and Oxidative Stress

  2023cites this paper
• The roles of natural triterpenoid saponins against Alzheimer's disease

  2023cites this paper
• The effect of NAC and Carnosine on alzheimer’s disease-related in vitro model through RAGE-AGE signaling pathway

  2023cites this paper
• American Ginseng for the Treatment of Alzheimer’s Disease: A Review

  2023cites this paper
• Modified Tacrine Derivatives as Multitarget-Directed Ligands for the Treatment of Alzheimer’s Disease: Synthesis, Biological Evaluation, and Molecular Modeling Study

  2023cites this paper
• Implication of the cooking oil-peroxidation product “hydroxynonenal” for Alzheimer’s disease

  2023cites this paper
• Spotlight on Coenzyme Q10 in scopolamine-induced Alzheimer's disease: oxidative stress/PI3K/AKT/GSK 3ß/CREB/BDNF/TrKB.

  2023cites this paper
• Extraction, isolation, synthesis, and biological evaluation of novel piperic acid derivatives for the treatment of Alzheimer’s disease

  2023cites this paper
• Effect of Curcumin and Coenzyme Q10 Alone and in Combination on Learning and Memory in an Animal Model of Alzheimer’s Disease

  2023cites this paper
• ACSL4-Mediated Ferroptosis and Its Potential Role in Central Nervous System Diseases and Injuries

  2023cites this paper
• Role of TPEN in Amyloid-β25–35-Induced Neuronal Damage Correlating with Recovery of Intracellular Zn2+ and Intracellular Ca2+ Overloading

  2023cites this paper
• Anti-Alzheimer, antioxidants, glucose-6-phosphate dehydrogenase effects of Taverniera glabra mediated ZnO and Fe2O3 nanoparticles in alloxan-induced diabetic rats

  2023cites this paper
• Oxidative Stress and Aging as Risk Factors for Alzheimer’s Disease and Parkinson’s Disease: The Role of the Antioxidant Melatonin

  2023cites this paper
• Magnetic resonance evidence of increased iron content in subcortical brain regions in asymptomatic Alzheimer's disease

  2023cites this paper
• Oxidative stress: culprit or consequence in Alzheimer’s amyloidopathy

  2023influential citation
• Active constituents of saffron (Crocus sativus L.) and their prospects in treating neurodegenerative diseases (Review)

  2023cites this paper
• Hsp70.1 carbonylation induces lysosomal cell death for lifestyle-related diseases

  2023cites this paper
• Therapeutic Implications of Probiotics in the Gut Microbe-Modulated Neuroinflammation and Progression of Alzheimer’s Disease

  2023cites this paper
• Functionalised penetrating peptide-chondroitin sulphate‑gold nanoparticles: Synthesis, characterization, and applications as an anti-Alzheimer's disease drug.

  2023cites this paper
• Anti-Neuroinflammatory Potential of Natural Products in the Treatment of Alzheimer’s Disease

  2023cites this paper
• Au nanoparticle decorated reduced graphene oxide and its electroanalytical characterization for label free dopamine detection

  2023cites this paper
• Discovery of novel deoxyvasicinone derivatives with benzenesulfonamide substituents as multifunctional agents against Alzheimer's disease.

  2023cites this paper
• Cognition Enhancing Potential of Aqueous Leaf Extract of Amaranthus dubius in Mice

  2023cites this paper
• Cordycepin, a bioactive compound from Cordyceps spp., moderates Alzheimer’s disease-associated pathology via anti-oxidative stress and autophagy activation

  2023cites this paper
• Targeting the microbiota-mitochondria crosstalk in neurodegeneration with senotherapeutics.

  2023cites this paper
• Early treatment with an M1 and sigma-1 receptor agonist prevents cognitive decline in a transgenic rat model displaying Alzheimer-like amyloid pathology.

  2023cites this paper
• Neuroprotective effect of ropinirole against Aβ1–42 ‐induced neurochemical perturbations and cognitive impairments in a rodent model

  2023cites this paper
• Design, synthesis, and biological evaluation of novel N-Benzyl piperidine derivatives as potent HDAC/AChE inhibitors for Alzheimer's disease.

  2023cites this paper
• Role of Oxidative Stress, Methionine Oxidation and Methionine Sulfoxide Reductases (MSR) in Alzheimer’s Disease

  2023cites this paper
• Nanoparticles for the potential treatment of Alzheimer’s disease: A physiopathological approach

  2023cites this paper
• Sirtuins and cognition: implications for learning and memory in neurological disorders

  2022influential citation
• A highly effective and stable butyrylcholinesterase inhibitor with multi-faceted neuroprotection and cognition improvement.

  2022cites this paper
• The Gut Microbiota-Brain Axis: A New Frontier on Neuropsychiatric Disorders

  2022cites this paper
• ER stress and UPR in Alzheimer’s disease: mechanisms, pathogenesis, treatments

  2022cites this paper
• Curcumin Scaffold as a Multifunctional Tool for Alzheimer’s Disease Research

  2022cites this paper
• Design, synthesis, and biological evaluation of novel 2-acetylphenol-rivastigmine hybrids as potential multifunctional agents for the treatment of Alzheimer’s disease

  2022cites this paper